Proficio Capital Partners LLC bought a new stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 126,785 shares of the company's stock, valued at approximately $14,995,000. Proficio Capital Partners LLC owned 0.05% of Cardinal Health as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Cardinal Health by 35.2% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company's stock valued at $3,871,000 after acquiring an additional 8,471 shares during the period. CHURCHILL MANAGEMENT Corp lifted its position in shares of Cardinal Health by 1.5% during the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company's stock valued at $28,435,000 after acquiring an additional 3,576 shares during the period. Geode Capital Management LLC lifted its position in shares of Cardinal Health by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company's stock valued at $633,298,000 after acquiring an additional 42,082 shares during the period. Consolidated Planning Corp lifted its position in shares of Cardinal Health by 40.0% during the 4th quarter. Consolidated Planning Corp now owns 8,926 shares of the company's stock valued at $1,056,000 after acquiring an additional 2,552 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of Cardinal Health by 2.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company's stock valued at $162,976,000 after acquiring an additional 33,388 shares during the period. 87.17% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
CAH has been the subject of several recent analyst reports. Argus set a $148.00 price objective on Cardinal Health in a research report on Tuesday, February 4th. Morgan Stanley upped their price objective on Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a research report on Friday, January 31st. Bank of America upgraded Cardinal Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $132.00 to $145.00 in a research report on Monday, January 6th. Citigroup upped their price objective on Cardinal Health from $120.00 to $129.00 and gave the stock a "neutral" rating in a research report on Friday, January 10th. Finally, JPMorgan Chase & Co. upped their price objective on Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $139.36.
View Our Latest Report on CAH
Cardinal Health Stock Performance
Shares of CAH stock traded up $1.33 on Tuesday, hitting $131.36. The company had a trading volume of 1,529,472 shares, compared to its average volume of 1,976,590. The firm has a market cap of $31.73 billion, a P/E ratio of 24.51, a P/E/G ratio of 1.49 and a beta of 0.66. The stock's 50-day moving average is $126.54 and its two-hundred day moving average is $119.56. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $132.84.
Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Equities research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.54%. Cardinal Health's dividend payout ratio is currently 37.69%.
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
